372 related articles for article (PubMed ID: 16275882)
21. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
Demir M; Acartürk E; Inal T; Attila G; Dönmez Y; Avkaroğullari M; Cayli M
Cardiovasc Pathol; 2007; 16(2):69-74. PubMed ID: 17317538
[TBL] [Abstract][Full Text] [Related]
22. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
[TBL] [Abstract][Full Text] [Related]
23. The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives.
Díez J; Laviades C; Orbe J; Zalba G; López B; González A; Mayor G; Páramo JA; Beloqui O
J Hypertens; 2003 Nov; 21(11):2085-92. PubMed ID: 14597852
[TBL] [Abstract][Full Text] [Related]
24. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
[TBL] [Abstract][Full Text] [Related]
25. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
[TBL] [Abstract][Full Text] [Related]
26. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.
Martos R; Baugh J; Ledwidge M; O'Loughlin C; Conlon C; Patle A; Donnelly SC; McDonald K
Circulation; 2007 Feb; 115(7):888-95. PubMed ID: 17283265
[TBL] [Abstract][Full Text] [Related]
27. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
Tuunanen H; Engblom E; Naum A; Scheinin M; Någren K; Airaksinen J; Nuutila P; Iozzo P; Ukkonen H; Knuuti J
J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
[TBL] [Abstract][Full Text] [Related]
28. [Diuretics in the treatment of heart failure: current pathophysiological aspects].
Mandinov L; Matter C; Kaufmann P; Hess OM
Praxis (Bern 1994); 1997 Apr; 86(14):575-82. PubMed ID: 9198852
[TBL] [Abstract][Full Text] [Related]
29. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
30. Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy.
Liang H; Müller J; Weng YG; Wallukat G; Fu P; Lin HS; Bartel S; Knosalla C; Pregla R; Hetzer R
Chin Med J (Engl); 2004 Mar; 117(3):401-7. PubMed ID: 15043781
[TBL] [Abstract][Full Text] [Related]
31. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
[TBL] [Abstract][Full Text] [Related]
32. Association of diabetes mellitus with myocardial collagen accumulation and relaxation impairment in patients with dilated cardiomyopathy.
Sakakibara M; Hirashiki A; Cheng XW; Bando Y; Ohshima K; Okumura T; Funahashi H; Ohshima S; Murohara T
Diabetes Res Clin Pract; 2011 Jun; 92(3):348-55. PubMed ID: 21414680
[TBL] [Abstract][Full Text] [Related]
33. Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
Mulder P; Mellin V; Favre J; Vercauteren M; Remy-Jouet I; Monteil C; Richard V; Renet S; Henry JP; Jeng AY; Webb RL; Thuillez C
Eur Heart J; 2008 Sep; 29(17):2171-9. PubMed ID: 18586661
[TBL] [Abstract][Full Text] [Related]
34. Surgical ventricular restoration in patients with ischemic dilated cardiomyopathy: evaluation of systolic and diastolic ventricular function, wall stress, dyssynchrony, and mechanical efficiency by pressure-volume loops.
Tulner SA; Steendijk P; Klautz RJ; Bax JJ; Schalij MJ; van der Wall EE; Dion RA
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):610-20. PubMed ID: 16935117
[TBL] [Abstract][Full Text] [Related]
35. Effect of right ventricular apex pacing on the Tei index and brain natriuretic peptide in patients with a dual-chamber pacemaker.
Ichiki H; Oketani N; Hamasaki S; Ishida S; Kataoka T; Ogawa M; Saihara K; Okui H; Fukudome T; Shinasato T; Kubozono T; Ninomiya Y; Matsushita T; Otsuji Y; Tei C
Pacing Clin Electrophysiol; 2006 Sep; 29(9):985-90. PubMed ID: 16981923
[TBL] [Abstract][Full Text] [Related]
36. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
37. The effect of cardiac fibrosis on left ventricular remodeling, diastolic function, and N-terminal pro-B-type natriuretic peptide levels in patients with nonischemic dilated cardiomyopathy.
Karaahmet T; Tigen K; Dundar C; Pala S; Guler A; Kilicgedik A; Cevik C; Mahmutyazicioglu K; Isiklar I; Basaran Y
Echocardiography; 2010 Sep; 27(8):954-60. PubMed ID: 20849483
[TBL] [Abstract][Full Text] [Related]
38. Increased (99m)Tc-sestamibi washout reflects impaired myocardial contractile and relaxation reserve during dobutamine stress due to mitochondrial dysfunction in dilated cardiomyopathy patients.
Hayashi D; Ohshima S; Isobe S; Cheng XW; Unno K; Funahashi H; Shinoda N; Okumura T; Hirashiki A; Kato K; Murohara T
J Am Coll Cardiol; 2013 May; 61(19):2007-17. PubMed ID: 23501381
[TBL] [Abstract][Full Text] [Related]
39. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
Ravassa S; Trippel T; Bach D; Bachran D; González A; López B; Wachter R; Hasenfuss G; Delles C; Dominiczak AF; Pieske B; Díez J; Edelmann F
Eur J Heart Fail; 2018 Sep; 20(9):1290-1299. PubMed ID: 29709099
[TBL] [Abstract][Full Text] [Related]
40. Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy.
Dumont CA; Monserrat L; Peteiro J; Soler R; Rodriguez E; Bouzas A; Fernández X; Pérez R; Bouzas B; Castro-Beiras A
Am J Cardiol; 2007 May; 99(10):1454-7. PubMed ID: 17493479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
